Cocrystal Pharma | 8-K: Cocrystal Pharma Reports Second Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
コクリスタル・ファーマ | 8-K：Cocrystal Pharmaは2024年第2四半期の決算を発表し、抗ウイルス薬開発プログラムの最新情報を提供します
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.